These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 33281436)

  • 1. Correction to: the Post-Pandemic World: between Constitutionalized and Authoritarian Orders - China's Narrative-Power Play in the Pandemic Era.
    Chang YY
    J Chin Polit Sci; 2021; 26(1):67-68. PubMed ID: 33281436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Post-Pandemic World: between Constitutionalized and Authoritarian Orders - China's Narrative-Power Play in the Pandemic Era.
    Chang YY
    J Chin Polit Sci; 2021; 26(1):27-65. PubMed ID: 33071536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
    Gao J; Zhang P
    Front Public Health; 2021; 9():756677. PubMed ID: 34976920
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic Policy Uncertainty (EPU) and China's Export Fluctuation in the Post-pandemic Era: An Empirical Analysis based on the TVP-SV-VAR Model.
    Hu G; Liu S
    Front Public Health; 2021; 9():788171. PubMed ID: 34938713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compensating for the 'Authoritarian Advantage' in Crisis Response: A Comparative Case Study of SARS Pandemic Responses in China and Taiwan.
    Schwartz J
    J Chin Polit Sci; 2012; 17(3):313-331. PubMed ID: 32288475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. China's Influence in Asia: How Do Individual Perceptions Matter?
    Xi J; Primiano C
    East Asia (Piscataway); 2020; 37(3):181-202. PubMed ID: 32837181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of China's public health system response to COVID-19.
    Zhang P; Gao J
    J Glob Health; 2021 Jan; 11():05004. PubMed ID: 33643637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 emergencies around the globe: China's experience in controlling COVID-19 and lessons learned.
    Jin H; Lu L; Liu J; Cui M
    Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 33320189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Privacy lost: Appropriating surveillance technology in China's fight against COVID-19.
    Liu J; Zhao H
    Bus Horiz; 2021; 64(6):743-756. PubMed ID: 34629478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Improvement of the reduction in catastrophic health expenditure in China's public health insurance.
    Wu D; Yu F; Nie W
    PLoS One; 2019; 14(2):e0213243. PubMed ID: 30811504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: An evolutionarily stable strategy and the critical point of hog futures trading entities based on replicator dynamic theory: 2006-2015 data for China's 22 provinces.
    Pang JB; Deng LF; Wang GY
    PLoS One; 2017; 12(8):e0182702. PubMed ID: 28763514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International institutions and China's health policy.
    Huang Y
    J Health Polit Policy Law; 2015 Feb; 40(1):41-71. PubMed ID: 25480846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. China's coal consumption in a globalizing world: Insights from Multi-Regional Input-Output and structural decomposition analysis.
    Wang Q; Song X; Liu Y
    Sci Total Environ; 2020 Apr; 711():134790. PubMed ID: 32000324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Use in China's Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018-2020.
    Yang Y; Geng X; Liu X; Wen X; Wu R; Cui D; Mao Z
    Front Pharmacol; 2022; 13():813213. PubMed ID: 35237164
    [No Abstract]   [Full Text] [Related]  

  • 15. China's COVID-19 Vaccination Strategy and Its Impact on the Global Pandemic.
    Meng Z; Shan S; Zhang R
    Risk Manag Healthc Policy; 2021; 14():4649-4655. PubMed ID: 34815726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Schistosomiasis control in the evolution of China's international discourse power].
    Zhou LY; Zhang JF; Li W; Yang K
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Oct; 33(5):518-522. PubMed ID: 34791852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
    Huang M; Wang J; Nicholas S; Maitland E; Guo Z
    J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. China's cement demand and CO
    Wei J; Cen K; Geng Y
    Environ Sci Pollut Res Int; 2019 Mar; 26(7):6409-6423. PubMed ID: 30623329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. China's Rise, World Order, and the Implications for International Business.
    Grosse R; Gamso J; Nelson RC
    Manag Int Rev; 2021; 61(1):1-26. PubMed ID: 33679004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic environmental efficiency analysis of China's power generation enterprises: a game cross-Malmquist index approach.
    Xie BC; Chen YF; Gao J; Zhang S
    Environ Sci Pollut Res Int; 2021 Jan; 28(2):1697-1711. PubMed ID: 32856243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.